Tatva Chintan Pharma rallies after Q1 PAT jumps more than two-fold
Mumbai, July 20 -- The company's consolidated net profit soared 140.3% to Rs 15.98 crore in Q1 FY27, compared with Rs 6.65 crore in Q1 FY26. Revenue from operations jumped 42.95% YoY to Rs 167.05 crore in the quarter ended 30th June 2026.
Profit before exceptional items and tax (PBT) increased 118.58% to Rs 15.41 crore in Q1 FY27 from Rs 7.05 crore in Q1 FY26. The company reported exceptional items of Rs 1.31 crore during the quarter.
EBITDA climbed 86% YoY to Rs 32.3 crore in Q1 FY27 from Rs 17.3 crore in the year-ago period. EBITDA margin improved to 19% from 15%, reflecting stronger operating performance.
During the quarter, Pharmaceuticals and Agrochemicals Intermediates and other Specialty Chemicals (PASC) contributed 35% of total...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.